Collegium Pharmaceutical (COLL) Change in Inventory (2016 - 2026)

Collegium Pharmaceutical's Change in Inventory history runs 11 years deep, the most recent figure standing at $1.8 million for Q1 2026.

• On a quarterly basis, Change in Inventory rose 10.31% year-over-year to $1.8 million in Q1 2026; TTM through Mar 2026 was $5.5 million, a 149.26% increase from a year earlier, with the FY2025 full-year figure at $5.4 million, up 138.44% from the prior year.
• Change in Inventory retreated to $1.8 million in Q1 2026 per COLL's latest filing, from $2.9 million in the prior quarter.
• Across five years, Change in Inventory topped out at $8.1 million in Q3 2023 and bottomed at -$18.2 million in Q4 2022.
• The 5-year median for Change in Inventory is -$1.8 million (2023), against an average of -$4.1 million.
• Across the five-year window, Change in Inventory tumbled 50516.67% in 2022 and jumped 257.01% in 2025, its largest moves.
• Year by year, Change in Inventory stood at -$18.2 million in 2022, then soared by 90.12% to -$1.8 million in 2023, then sank by 37.87% to -$2.5 million in 2024, then surged by 215.74% to $2.9 million in 2025, then sank by 36.07% to $1.8 million in 2026.
• Per Business Quant, the three latest COLL Change in Inventory figures stand at $1.8 million (Q1 2026), $2.9 million (Q4 2025), and -$96000.0 (Q3 2025).